IPP Bureau
Glenmark to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 diabetes
By IPP Bureau - October 18, 2023
Glenmark's Zita portfolio of medicines have been benefiting around 1.75 million Type 2 diabetic patients annually
USFDA inspection at Biocon Biologics' manufacturing facility in Johor, Malaysia
By IPP Bureau - October 18, 2023
Shilpa Medicare Unit IV, Jadcherla has cleared TGA, Australia GMP inspection
By IPP Bureau - October 18, 2023
This inspection is the fourth major regulatory inspection (after Russia, Canada and Brazil), cleared by this site in the past two years
Glenmark receives ANDA approval for Apremilast Tablets
By IPP Bureau - October 18, 2023
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Piramal Pharma launches in-vitro biology capabilities at Ahmedabad discovery services site
By IPP Bureau - October 17, 2023
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Lupin enters into BTA with Lupin Manufacturing Solutions
By IPP Bureau - October 17, 2023
Lupin enters into BTA with Lupin Manufacturing Solutions
Satish Pandurang Samant appointed CEO of Vineet Laboratories
By IPP Bureau - October 16, 2023
He has 37 years of experience in API Intermediaries, Pharma and Chemicals industr
Mankind Pharma appoints Prateek Dubey as President - Global CHRO
By IPP Bureau - October 16, 2023
Prateek has more than 23 years of rich experience in Human Resource
Ipca appoints Hitesh Kumar Maheshwari as President – R&D (Formulations)
By IPP Bureau - October 16, 2023
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
Zydus appoints Punit Patel as President and CEO, Americas
By IPP Bureau - October 16, 2023
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines
By IPP Bureau - October 16, 2023
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
ImmunoACT announces the approval of India's first CAR-T cell therapy 'NexCAR19'
By IPP Bureau - October 16, 2023
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities
By IPP Bureau - October 16, 2023
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
Evonik and Shandong Vland Biotech form JV in China with focus on gut health products for animals
By IPP Bureau - October 14, 2023
Evonik China and Shandong Vland Biotech agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally
Philips Visual Patient Avatar pioneers at-a-glance patient data for faster, better decision-making in the operating room
By IPP Bureau - October 14, 2023
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
